Alisol G

CAS No. 155521-46-3

Alisol G( Alisol-G | 25-Anhydroalisol A )

Catalog No. M29616 CAS No. 155521-46-3

Alisol G is isolated from Rhizoma Alismatis and exhibits hCE2 inhibitory effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 188 In Stock
2MG 112 In Stock
5MG 187 In Stock
10MG 275 In Stock
25MG 465 In Stock
50MG 649 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Alisol G
  • Note
    Research use only, not for human use.
  • Brief Description
    Alisol G is isolated from Rhizoma Alismatis and exhibits hCE2 inhibitory effects.
  • Description
    Alisol G is isolated from Rhizoma Alismatis and exhibits hCE2 inhibitory effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Alisol-G | 25-Anhydroalisol A
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    155521-46-3
  • Formula Weight
    472.71
  • Molecular Formula
    C30H48O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@@]12CCC3(C)C(C(O)CC4=C(CC[C@]34C)C(C)C[C@H](O)[C@@H](O)C(C)=C)[C@@]1(C)CCC(=O)C2(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Talmetacin

    Talmetacin has anti-inflammatory and analgesic and anti-tumour activity and can be used to study cardiovascular disease.

  • protoheme

    protoheme used as nutrient fortifier, blood tonic and food additive for iron.

  • Eugeniin

    Tellimagrandin II (Eugeniin), with oral activity, is the first intermediate of the ellagitannin series derived from 4C1-glucose. It inhibits the resistance of Staphylococcus aureus by disrupting the integrity of the cell wall, leading to the loss of cytoplasmic contents. Additionally, Tellimagrandin II exhibits anti-inflammatory effects and inhibits acetylcholinesterase (AChE) activity, improving memory impairment. Tellimagrandin II holds potential for research in the fields of antibacterial, anti-inflammatory, and neurodegenerative diseases.